Cargando…
Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence
Hypertension is an important risk factor for premature death as it increases the probability of stroke, myocardial infarction, and heart failure. Antihypertensive drugs can decrease cardiovascular (CV) morbidity and mortality. The majority of hypertensive patients need more than one antihypertensive...
Autores principales: | Antza, Christina, Stabouli, Stella, Kotsis, Vasilios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118038/ https://www.ncbi.nlm.nih.gov/pubmed/27895487 http://dx.doi.org/10.2147/VHRM.S91020 |
Ejemplares similares
-
Lercanidipine/enalapril combination in the management of obesity-related hypertension
por: Grassi, Guido
Publicado: (2016) -
Fixed combinations in the management of hypertension: perspectives on lercanidipine – enalapril
por: Barrios, Vivencio, et al.
Publicado: (2008) -
Fixed combination of lercanidipine and enalapril in the management of hypertension: focus on patient preference and adherence
por: Borghi, Claudio, et al.
Publicado: (2012) -
American, European and international hypertension guidelines: Time to shake hands?
por: Antza, Christina, et al.
Publicado: (2020) -
Fixed combination of lercanidipine and enalapril in the management of hypertension; focus on patient preference and adherence [Corrigendum]
Publicado: (2013)